Risk factors and outcomes for respiratory syncytial virus-related infections in immunocompromised children

Pediatric Infectious Disease Journal

Volumn 32, Issue 10, 2013, Pages 1073-1076

  Allen, Upton ^a   Asner, Sandra ^a   Stephens, Derek ^b   Pedulla, Paul ^a   Richardson, Susan E ^a,c   Robinson, Joan ^d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Immunocompromised children; Nosocomial respiratory syncytial virus infection; Respiratory syncytial virus

Indexed keywords

ARTICLE; CHILD; COHORT ANALYSIS; COMMUNICABLE DISEASE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOFLUORESCENCE; INFECTION RISK; INTENSIVE CARE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONPARAMETRIC TEST; NOSE SMEAR; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TREATMENT OUTCOME; VIRUS IDENTIFICATION;

ANALYSIS OF VARIANCE; CHILD, PRESCHOOL; COHORT STUDIES; CROSS INFECTION; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; LENGTH OF STAY; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84891829447     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31829dff4d     Document Type: Article

References (23)

1. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. JPediatr. 2003;143(suppl 5): S127-S132.
2. Chávez-Bueno S, Mejías A, Merryman RA, et al. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J. 2007;26: 1089-1093.
3. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr. 1992;121: 348-354.
4. Abdallah A, Rowland KE, Schepetiuk SK, et al. An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: effect on engraftment and outcome of pneumonia without specific antiviral treatment. Bone Marrow Transplant. 2003;32: 195-203.
5. Raboni SM, Nogueira MB, Tsuchiya LR, et al. Respiratory tract viral infections in bone marrow transplant patients. Transplantation. 2003;76: 142-146.
6. McCarthy AJ, Kingman HM, Kelly C, et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant. 1999;24: 1315-1322.
7. Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood. 2011;117: 2755-2763.
8. Boeckh M, Englund J, Li Y, et al.; NIAID Collaborative Antiviral Study Group. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis. 2007;44: 245-249.
9. Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. 1992;165: 987-993.
10. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis. 1996;22: 778-782.
11. Khanna N, Widmer AF, Decker M, et al. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis. 2008;46: 402-412.
12. Blanchard SS, Gerrek M, Siegel C, et al. Significant morbidity associated with RSV infection in immunosuppressed children following liver transplantation: case report and discussion regarding need of routine prophylaxis. Pediatr Transplant. 2006;10: 826-829.
13. Gemmill I. National Advisory Committee on Immunization (NA CI). Statement on thimerosal. Can Commun Dis Rep. 2003;29: 1-10.
14. Ljungman P, Ward KN, Crooks BN, et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2001;28: 479-484.
15. Langley JM, LeBlanc JC, Wang EE, et al. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a Pediatric Investigators Collaborative Network on Infections in Canada Study. Pediatrics. 1997;100: 943-946.
16. Canadian Institute for Health Information. Available at: http://www.cihi.ca/CIHI-ext-portal/internet/EN/Home/home/cihi000001. Accessed July 20, 2013.
17. Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr. 1995;126: 212-219.
18. Adams R, Christenson J, Petersen F, et al. Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV. Bone Marrow Transplant. 1999;24: 661-664.
19. Simon A, Müller A, Khurana K, et al.; DSM RSV Paed Study Group. Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection-results from a prospective multicenter German surveillance study. Int J Hyg Environ Health. 2008;211: 241-250.
20. Forster J, Ihorst G, Rieger CH, et al. Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). Eur J Pediatr. 2004;163: 709-716.
21. Hall CB. Nosocomial respiratory syncytial virus infections: the "Cold War" has not ended. Clin Infect Dis. 2000;31: 590-596.
22. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med. 1997;102(3A): 2-9; discussion 25.
23. Kristensen K, Hjuler T, Ravn H, et al. Chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based cohort study. Clin Infect Dis. 2012;54: 810-817.